|
2020 Journal Article Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working GroupAmgad, Mohamed, Stovgaard, Elisabeth Specht, Balslev, Eva, Thagaard, Jeppe, Chen, Weijie, Dudgeon, Sarah, Sharma, Ashish, Kerner, Jennifer K., Denkert, Carsten, Yuan, Yinyin, AbdulJabbar, Khalid, Wienert, Stephan, Savas, Peter, Voorwerk, Leonie, Beck, Andrew H., Madabhushi, Anant, Hartman, Johan, Sebastian, Manu M., Horlings, Hugo M., Hudeček, Jan, Ciompi, Francesco, Moore, David A., Singh, Rajendra, Roblin, Elvire, Balancin, Marcelo Luiz, Mathieu, Marie-Christine, Lennerz, Jochen K., Kirtani, Pawan, Chen, I-Chun ... International Immuno-Oncology Biomarker Working Group (2020). Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer, 6 (1) 16, 16. doi: 10.1038/s41523-020-0154-2 |
|
2020 Journal Article Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline updateAllison, Kimberly H., Hammond, M. Elizabeth H., Dowsett, Mitchell, McKernin, Shannon E., Carey, Lisa A., Fitzgibbons, Patrick L., Hayes, Daniel F., Lakhani, Sunil R., Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M., Regan, Meredith M., Rimm, David L., Symmans, W. Fraser, Torlakovic, Emina E., Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F., McShane, Lisa M. and Wolff, Antonio C. (2020). Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update. Archives of Pathology and Laboratory Medicine, 144 (5), 545-563. doi: 10.5858/arpa.2019-0904-SA |
|
2020 Conference Publication Characterising clinicopathological and biological parameters predictive of outcome for patients diagnosed with invasive lobular carcinomaSimpson, P., Reed, A. McCart, Kutasovic, J., Coorey, C., Kuo, L., Nguyen, H., Pei, W., Ong, J., Sokolova, A., Evans, E., Porter, A. and Lakhani, S. (2020). Characterising clinicopathological and biological parameters predictive of outcome for patients diagnosed with invasive lobular carcinoma. ESMO Breast Cancer Virtual Meeting, Online, 23-24 May 2020. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2020.03.186 |
|
2020 Journal Article Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline updateAllison, Kimberly H., Hammond, M. Elizabeth H., Dowsett, Mitchell, McKernin, Shannon E., Carey, Lisa A., Fitzgibbons, Patrick L., Hayes, Daniel F., Lakhani, Sunil R., Chavez-MacGregor, Mariana, Perlmutter, Jane, Perou, Charles M., Regan, Meredith M., Rimm, David L., Symmans, W. Fraser, Torlakovic, Emina E., Varella, Leticia, Viale, Giuseppe, Weisberg, Tracey F., McShane, Lisa M. and Wolff, Antonio C. (2020). Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. Journal of Clinical Oncology, 38 (12), 1346-1366. doi: 10.1200/JCO.19.02309 |
|
2020 Journal Article American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implicationsSchnitt, Stuart J., Brogi, Edi, Chen, Yunn-Yi, King, Tari A. and Lakhani, Sunil R. (2020). American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications. Annals of Diagnostic Pathology, 45 151481, 151481. doi: 10.1016/j.anndiagpath.2020.151481 |
|
2020 Journal Article Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast CancerKutasovic, Jamie R., McCart Reed, Amy E., Sokolova, Anna, Lakhani, Sunil R. and Simpson, Peter T. (2020). Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer. Cancers, 12 (4) 848, 848. doi: 10.3390/cancers12040848 |
|
2020 Journal Article Pitfalls and controversies in pathology impacting breast cancer managementKim, Woo Gyeong, Cummings, Margaret C. and Lakhani, Sunil R. (2020). Pitfalls and controversies in pathology impacting breast cancer management. Expert Review of Anticancer Therapy, 20 (3), 205-219. doi: 10.1080/14737140.2020.1738222 |
|
2020 Journal Article The 2019 WHO classification of tumours of the breastHoon Tan, Puay, Ellis, Ian, Allison, Kimberly, Brogi, Edi, Fox, Stephen B., Lakhani, Sunil, Lazar, Alexander J., Morris, Elizabeth A., Sahin, Aysegul, Salgado, Roberto, Sapino, Anna, Sasano, Hironobu, Schnitt, Stuart, Sotiriou, Christos, van Diest, Paul, White, Valerie A., Lokuhetty, Dilani, Cree, Ian A. and WHO Classification of Tumours Editorial Board (2020). The 2019 WHO classification of tumours of the breast. Histopathology, 77 (2) his.14091, 181-185. doi: 10.1111/his.14091 |
|
2020 Journal Article Pan-cancer analysis of whole genomesCampbell, Peter J., Getz, Gad, Korbel, Jan O., Stuart, Joshua M., Jennings, Jennifer L., Stein, Lincoln D., Perry, Marc D., Nahal-Bose, Hardeep K., Ouellette, B. F. Francis, Li, Constance H., Rheinbay, Esther, Nielsen, G. Petur, Sgroi, Dennis C., Wu, Chin-Lee, Faquin, William C., Deshpande, Vikram, Boutros, Paul C., Lazar, Alexander J., Hoadley, Katherine A., Louis, David N., Dursi, L. Jonathan, Yung, Christina K., Bailey, Matthew H., Saksena, Gordon, Raine, Keiran M., Buchhalter, Ivo, Kleinheinz, Kortine, Schlesner, Matthias, Zhang, Junjun ... Hamdy, Freddie C. (2020). Pan-cancer analysis of whole genomes. Nature, 578 (7793), 82-93. doi: 10.1038/s41586-020-1969-6 |
|
2020 Journal Article Non-coding RNAs underlie genetic predisposition to breast cancerMoradi Marjaneh, Mahdi, Beesley, Jonathan, O'Mara, Tracy A., Mukhopadhyay, Pamela, Koufariotis, Lambros T., Kazakoff, Stephen, Hussein, Nehal, Fachal, Laura, Bartonicek, Nenad, Hillman, Kristine M., Kaufmann, Susanne, Sivakumaran, Haran, Smart, Chanel E., McCart Reed, Amy E., Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., Barnes, Daniel R., Antoniou, Antonis C., Dinger, Marcel E., Waddell, Nicola, Easton, Douglas F., Dunning, Alison M., Chenevix-Trench, Georgia, Edwards, Stacey L. and French, Juliet D. (2020). Non-coding RNAs underlie genetic predisposition to breast cancer. Genome Biology, 21 (1) 7, 7. doi: 10.1186/s13059-019-1876-z |
|
2020 Book Chapter Columnar cell lesionsCummings, Margaret C., Simpson, Peter T. and Lakhani, Sunil R. (2020). Columnar cell lesions. Breast Pathology. Encyclopedia of Pathology. (pp. 71-79) edited by Anna Sapino and Janina Kulka. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-62539-3 |
|
2020 Conference Publication Remodelling of calcium influx pathways in breast cancer associated fibroblastsSadras, Francisco, Stewart, Teneale A., Robitaille, Melanie, Peters, Amelia A., Kalita-de Croft, Priyakshi, Soon, Patsy, Saunus, Jodi M., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Remodelling of calcium influx pathways in breast cancer associated fibroblasts. 2019 San Antonio Breast Cancer Symposium, San Antonio, TX United States, 10-14 December 2019. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.sabcs19-p6-06-15 |
|
2020 Journal Article The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practiceGonzalez-Ericsson, Paula I., Stovgaard, Elisabeth S., Sua, Luz F., Reisenbichler, Emily, Kos, Zuzana, Carter, Jodi M., Michiels, Stefan, Le Quesne, John, Nielsen, Torsten O., Lænkholm, Anne-Vibeke, Fox, Stephen B., Adam, Julien, Bartlett, John M.S., Rimm, David L., Quinn, Cecily, Peeters, Dieter, Dieci, Maria V., Vincent-Salomon, Anne, Cree, Ian, Hida, Akira I., Balko, Justin M., Haynes, Harry R., Frahm, Isabel, Acosta-Haab, Gabriela, Balancin, Marcelo, Bellolio, Enrique, Yang, Wentao, Kirtani, Pawan, Sugie, Tomoharu ... Sanders, Melinda (2020). The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. Journal of Pathology, 250 (5), 667-684. doi: 10.1002/path.5406 |
|
2020 Conference Publication Calcium communication in an in vitro model of breast cancer brain metastasesChalmers, Silke B., Sadras, Francisco, Saunus, Jodi , Lakhani, Sunil , Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2020). Calcium communication in an in vitro model of breast cancer brain metastases. ASCEPT-APSA Joint virtual scientific meeting 2020, Virtual meeting, 24-26 November 2020. |
|
2020 Journal Article Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patientsMcKenzie, Hayley S., Maishman, Tom, Simmonds, Peter, Durcan, Lorraine, Altman, Douglas G., Jones, Louise, Evans, Gareth, Thompson, Alastair M., Pharaoh, Paul, Hanby, Andrew, Lakhani, Sunil, Eeles, Ros, Gilbert, Fiona J., Hamed, Hisham, Hodgson, Shirley, Simmonds, Peter, Eccles, Diana, Eccles, Diana, Copson, Ellen and POSH Steering Group (2020). Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients. British Journal of Cancer, 122 (11), 1618-1629. doi: 10.1038/s41416-020-0784-z |
|
2019 Journal Article Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)Li, Anqi, Geyer, Felipe C., Blecua, Pedro, Lee, Ju Youn, Selenica, Pier, Brown, David N., Pareja, Fresia, Lee, Simon S. K., Kumar, Rahul, Rivera, Barbara, Bi, Rui, Piscuoglio, Salvatore, Wen, Hannah Y., Lozada, John R., Gularte-Mérida, Rodrigo, Cavallone, Luca, Aghmesheh, Morteza, Amor, David, Andrews, Leslie, Antill, Yoland, Balleine, Rosemary, Beesley, Jonathan, Blackburn, Anneke, Bogwitz, Michael, Brown, Melissa, Burgess, Matthew, Burke, Jo, Butow, Phyllis, Caldon, Liz ... Reis-Filho, Jorge S. (2019). Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9). npj Breast Cancer, 5 (1) 44. doi: 10.1038/s41523-019-0140-8 |
|
2019 Journal Article Development and validation of a targeted gene sequencing panel for application to disparate cancersMcCabe, Mark J., Gauthier, Marie-Emilie A., Chan, Chia-Ling, Thompson, Tanya J., De Sousa, Sunita M.C., Puttick, Clare, Grady, John P., Gayevskiy, Velimir, Tao, Jiang, Ying, Kevin, Cipponi, Arcadi, Deng, Niantao, Swarbrick, Alex, Thomas, Melissa L., Lord, Reginald V., Johns, Amber L., Kohonen-Corish, Maija, O’Toole, Sandra A., Clark, Jonathan, Mueller, Simon A., Gupta, Ruta, McCormack, Ann I., Dinger, Marcel E., Cowley, Mark J., Aghmesheh, Morteza, Amor, David, Andrews, Lesley, Antill, Yoland, Armitage, Shane ... Young, Mary-Anne (2019). Development and validation of a targeted gene sequencing panel for application to disparate cancers. Scientific Reports, 9 (1) 17052, 17052. doi: 10.1038/s41598-019-52000-3 |
|
2019 Journal Article LobSig is a multigene predictor of outcome in invasive lobular carcinomaMcCart Reed, Amy E., Lal, Samir, Kutasovic, Jamie R., Wockner, Leesa, Robertson, Alan, de Luca, Xavier M., Kalita-de Croft, Priyakshi, Dalley, Andrew J., Coorey, Craig P., Kuo, Luyu, Ferguson, Kaltin, Niland, Colleen, Miller, Gregory, Johnson, Julie, Reid, Lynne E., Males, Renique, Saunus, Jodi M., Chenevix-Trench, Georgia, Coin, Lachlan, Lakhani, Sunil R. and Simpson, Peter T. (2019). LobSig is a multigene predictor of outcome in invasive lobular carcinoma. npj Breast Cancer, 5 (1) 18, 18. doi: 10.1038/s41523-019-0113-y |
|
2019 Journal Article Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene, (2017), 36, 33, (4802-4809), 10.1038/onc.2017.21)Hernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M. and Freire, R. (2019). Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene, (2017), 36, 33, (4802-4809), 10.1038/onc.2017.21). Oncogene, 38 (24), 4886-4886. doi: 10.1038/s41388-019-0753-2 |
|
2019 Journal Article ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in AustraliaFarshid, Gelareh, Bilous, Michael, Morey, Adrienne, Fox, Stephen, Lakhani, Sunil, Loi, Sherene, Bell, Richard and Spillane, Andrew (2019). ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia. Pathology, 51 (4), 345-348. doi: 10.1016/j.pathol.2019.02.004 |
